State Medicaid programs must cover medication assisted treatment under a new mandatory benefit that takes effect today.

The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018 added the benefit to increase access to evidenced-based treatment for opioid use disorder for Medicaid beneficiaries.

Specifically, states must cover all forms of drugs and biologicals that the Food and Drug Administration has approved or licensed for MAT to treat OUD, the Centers for Medicare & Medicaid Services said today in a reminder notice

 

Related News Articles

Headline
Children and adults in Medicaid and the Children’s Health Insurance Program used 26 million fewer mental care health services between March and October 2020…
Headline
The Centers for Medicare & Medicaid Services yesterday released guidance on how states can receive a 10-percentage-point increase in their federal…
Headline
The Government Accountability Office yesterday named five new members to the Medicaid and CHIP Payment and Access Commission, which advises Congress on…
Headline
The AHA and Texas Hospital Association today filed a friend-of-the-court brief supporting the Texas Health and Human Services Commission and several Texas…
Headline
A recent Health Affairs Blog post by physicians “gives an incomplete account of the implications of allowing new and expanded physician-owned hospitals to bill…
Blog
A recent Health Affairs post gives an incomplete account of the implications of allowing new and expanded physician-owned hospitals to bill Medicare and…